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Introduction
Having a mother, sister, or daughter with a breast cancer diagnosis is a well-known risk factor for breast cancer.(1) Among African American women, estimates of the relative risk for first degree family history of breast cancer range from 1.65 to1.78,(2, 3) similar to findings from studies of European American and Asian women. (1, 4, 5) Among studies that reported results separately for estrogen receptor (ER) positive and ER-breast cancer, most reported similar associations by subtype, (3, (6) (7) (8) (9) (10) (11) while one reported a stronger association with ER+ cancer (12) and two reported a stronger relation for ER-breast cancer. (13, 14) Only the Black Women's Health Study reported on family history separately for ER+ and ER-breast cancer in African American women, with similar increases by subtype, but findings were based on small numbers. (3) A first degree family history of cancers other than breast cancer may also increase breast cancer risk. Family history of prostate, (15, 16) lung, (17) ovarian, (18) and colon or colorectal cancer (3, 16) have been associated with greater risk of breast cancer in some, but not all studies that examined specific other cancers. In studies that examined combinations of cancers, risk of breast cancer was elevated for family history of breast and prostate cancers, (15) breast and ovarian cancers, (19, 20) and breast and colorectal cancers. (16, 21, 22) Among African American women, family histories of lung cancer,(23) colon cancer,(3) or both breast and prostate cancer (16) were associated with increased risk of breast cancer.
The objective of the present study was to investigate the relation of first degree family history of breast and other cancers to risk of ER+, ER-, and triple negative breast cancer in African American women.
Materials and methods
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The African American Breast Cancer Epidemiology and Risk (AMBER) Consortium has been described in detail elsewhere. (24) The AMBER Consortium pools data on African American women from two cohort studies, the Black Women's Health Study and the Multiethnic Cohort Study, and two case-control studies, the Carolina Breast Cancer Study and the Women's Circle of Health Study. Informed consent was provided to each study by its participants. Each study and the consortium were approved by the relevant Institutional Review Boards.
The Black Women's Health Study (BWHS) is a prospective cohort study that enrolled 59,000 African American women across the United States in 1995. (25) Participants were years old at baseline when they completed an extensive health questionnaire and are followed with biennial questionnaires for data on incident diagnoses and other factors. Incident breast cancers are identified through self-report on questionnaires or through linkage to state cancer registries. For the AMBER Consortium, a nested case-control study was created; cohort participants without breast cancer were frequency-matched to cases based on age (5-year categories), geographic region, and most recent completed questionnaire. Each study confirmed incident breast cancer cases with data on ER, progesterone receptor (PR), and human epidermal growth factor 2 receptor (HER2) obtained from medical records and/or state cancer registries.(24) Cases were classified as ER+, ER-, and triple negative (TN; ER-/PR-/HER2-). Of the 5,736 potential cases, ER status was available for 4,520 cases (79%) at the time of this analysis. PR status was available for 4,301 cases (75%); HER2 status was available for fewer cases (2,927, 51%), due to more recent inclusion of HER2 in routine testing. There were no statistically significant differences between women with and without known receptor status by age or family history of breast cancer. In total, there were 3,023 ER+ cases, 1,497 ER-cases (including 696 triple negative cases), and 17,420 controls. Participants were asked whether any parent, sibling, or child (first degree relative) had been diagnosed with breast cancer and whether the relative was diagnosed before age 50.
Participants were also asked about first degree family history of ovarian, colorectal, prostate, lung, and cervical cancer, and lymphoma or leukemia.
Each study obtained detailed data on most known and suspected risk factors for breast cancer. Variables were centrally harmonized and evaluated as risk factors for breast cancer overall and for ER+, ER-, and TN breast cancer. (24, (30) (31) (32) (33) 
Statistical analysis
Multinomial logistic regression models were used to calculate odds ratios (ORs) and 95% 
Results
The prevalences of first degree family history of breast cancer and of cancers other than breast cancer were largely similar across studies (Table 1) ; the differences were statistically significant due to the large sample size. Among controls, 9.3% had a first degree relative with breast cancer and 22.7% had a first degree relative with a cancer other than breast cancer. Few controls had first-degree family history of both breast cancer and another cancer site (2.9%).
Lung cancer was the most common other cancer among first degree relatives (7.7%), followed by prostate (7.6%) and colorectal cancer (6.2%).
The ORs for a first degree family history of breast cancer were similar by subtype: ER+ In assessing the relation of family history of other cancers to breast cancer risk, we looked first at risk of overall breast cancer. A first degree family history of breast cancer alone (with no other cancers among first degree relatives) was associated with a 1.58-fold risk (95% CI 1.38-1.82) ( Table 3 ). The ORs for family history of each of the other cancers alone were close to 1.0, with the exception of cervical cancer, for which the OR for the association with overall breast cancer risk was 1.53 (0.94-2.47). Risk of breast cancer was tripled in women who had a family history of both breast and prostate cancer (OR=3.02, 95% CI 2.19-4.16, pinteraction<0.01). The OR for a family history of both breast and cervical cancer was 3.56 (95% CI 0.99-12.85), but this estimate was based on only 7 exposed breast cancer cases. Risk of breast cancer was significantly increased for women with a family history of three or more cancer sites, but only when breast cancer was one of the sites.
Next, we considered family history of a cancer diagnosis in relation to risk of specific breast cancer subtypes. The ORs for first degree family history of breast cancer alone were similar for ER+, ER-, and TN breast cancer ( 
Discussion
This large study provides convincing evidence that first degree family history of breast cancer is associated with ER+, ER-, and TN breast cancer in African American women and that having a relative diagnosed with breast cancer at a young age is a strong predictor of risk. 
TN breast cancer. In addition, we observed an unexpected association of family history of cervical cancer with increased risk of ER-breast cancer.
Previous studies with data on African American women have also shown family history of breast cancer to be a strong risk factor for breast cancer. (2, 3, 16, 36-39 ) Only the BWHS and the Women's CARE study also considered the relative's age at diagnosis, and both observed a greater risk of breast cancer when the relative was diagnosed at a younger age. (2, 3) In the only study to present data in African American women by subtype, the BWHS, a similar increase was observed across subtypes. (3) Findings according to subtype from other populations have been mixed. The association with family history of breast cancer has been similar across breast cancer subtypes, (3, (6) (7) (8) (9) (10) (11) 40) stronger for ER+ breast cancer, (12, 41) and stronger for ER-or TN breast cancer. (13, 14, 42) The strongest evidence comes from a pooled analysis of 12 studies in the Breast Cancer Association Consortium, where an association with family history of breast cancer was present across subtypes, but with a stronger association for basal-like breast cancer. (40) Only a few studies of African Americans have examined the relation of family history of cancers other than breast cancer to risk of breast cancer. (3, 16) In the BWHS, a family history of colon cancer was associated with increased risk of breast cancer, with a relative risk estimate of Analyses of data from The Cancer Genome Atlas and other genomic data suggest that there are etiologic links between ovarian cancer and basal-like breast cancer,(70-73) which is primarily comprised of TN tumors. Consistent with those data, we observed a non-significant 53% increase in risk of TN breast cancer associated with a first degree family history of ovarian cancer. Genomic analyses also suggest that there are biologic similarities between basal-like breast cancer and lung cancer. (72, 73) In our data, the risk of TN breast cancer was significantly increased for a first degree family history of lung cancer only in the presence of a first degree family history of breast cancer.
African American women experience a higher prevalence of early onset breast cancer and of ER-breast cancer compared to European American women. (74) (75) (76) Because of the large sample size, we were able to informatively assess breast cancer risk by age and for breast cancer subtypes. We were also able to assess family history of cancers other than breast cancer. We controlled for multiple potential confounding factors. Participants' self-report of family history may have been incomplete and could have been subject to recall bias in the case-control studies.
However, previous validation studies have shown that self-reported family cancer histories for first degree relatives are accurate for breast cancer (77) and results were similar across our studies, which included cohort studies in which family history data were provided before the participant was diagnosed with breast cancer. Additionally, the prevalence of family history of breast cancer among controls in the AMBER Consortium (9.3%) was similar to the prevalence in other studies. (78, 79) We did not have data on all cancer sites that may be of interest, such as the endometrium and pancreas.
In summary, the present findings suggest that family history of cancers other than breast cancer may indicate a higher inherited genetic susceptibility to breast cancer. Women who had Tables   Table 1. Characteristics of cases and controls in the AMBER Consortium, by study. (25) 307 (25) 830 (18) (9) 132 (16) 88 (11) 140 (15) 385 (8) 184 (17) 141 (12) 726 (16) 22 (1) 88 (1) 32 (4) 17 (2) 22 (2) 87 (2) 28 (3) 33 (3) 103 (2) 224 ( ) 25 (0) 20 (3) 18 (2) 10 (1) 28 (1) 19 (2) 19 (2) 55 (1) 
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